House Panel Adds Pay-For-Delay Ban To Health Bill

Law360, New York (August 3, 2009, 2:34 PM EDT) -- As part of a health care reform package up for debate in the fall, the U.S. House of Representatives Energy and Commerce Committee has voted to add a provision banning so-called pay-for-delay deals between brand-name pharmaceutical manufacturers and generics competitors.

Committee members on Friday voted to approve an amendment outlawing reverse payments to generic-drug companies in exchange for promises to keep competing generics off the market, shortly before signing off on the health care legislation, by a vote of 31-28. The amendment was sponsored by Rep....
To view the full article, register now.